Skip to content
Text “Loti” to 833-962-6682 to join the Loti Labs VIP Group!
Loti Labs Resources Peptides

Prostamax Peptide (KEDP): What the Published Research Shows

What the published literature actually shows about the Prostamax tetrapeptide (KEDP), from chromatin studies to the replication gaps worth noting.

Prostamax is four amino acids long. Lys-Glu-Asp-Pro, written KEDP, with a molecular formula of C20H33N5O9 and a mass of 487.5 g/mol on PubChem [1]. Four residues puts it at the very short end of anything a chemist would call a peptide.

And yet the lab work on it isn’t about a receptor or an enzyme. It’s about chromatin. Most of what’s been published asks one odd question: can a tetrapeptide loosen tightly packed DNA in cells from elderly donors?

We read every PubMed record we could find for Prostamax and KEDP. Here’s what’s in them, and where the gaps are.

Where Prostamax comes from

Prostamax belongs to the short peptide “bioregulator” family developed by Vladimir Khavinson’s group at the St. Petersburg Institute of Bioregulation and Gerontology [2]. Its better-known relatives include Epithalon and Vilon. The working idea behind the family, as its authors describe it, is that very short peptides, two to four residues, interact with DNA and gene regulation in a tissue-specific way.

Our Khavinson bioregulators guide covers the whole family. This page sticks to KEDP.

The chromatin studies

The core paper is from 2004. Khavinson, Lezhava and Malinin exposed leukocytes from people aged 75 to 88 to five short peptides, Prostamax among them. Every peptide activated ribosomal genes and decondensed tightly packed chromatin fibrils. Three of them, Prostamax included, also decondensed the pericentromeric structural heterochromatin of chromosome 1 [2].

Lezhava’s group came back to KEDP in 2012 with lymphocytes from donors aged 75 to 86. The numbers are specific enough to plan around:

  • Sister chromatid exchanges rose to 12.0 per cell, against 5.9 in unexposed cells.
  • Ag-positive nucleolar organizer regions rose to 2.5 per cell, against 0.95.
  • Large pericentromeric heterochromatin variants on chromosomes 1 and 9 became less frequent [3].

Notice the chromosome 9 result. In the 2004 paper, the chromosome 9 change was attributed to Epithalon and Livagen, with Prostamax listed only for chromosome 1 [2]. The 2012 study reports chromosome 9 for Prostamax too [3]. Different donors and cell preparations, eight years apart, with Lezhava on both author lists. It’s a small discrepancy, but it’s the kind a replication study could settle.

A third angle came from physics. Meskhi and colleagues ran microcalorimetry on lymphocyte chromatin in 2004 and found that Prostamax shifted two melting endotherms to lower temperatures, by 2.9 and 1.0 degrees C. They read that as partial relaxation of the 30 nm chromatin fiber toward the 10 nm filament [4]. It’s indirect evidence. Still, it lines up with the cytogenetic results.

Does KEDP touch DNA directly?

Possibly. In 2015, Solovyev’s team measured DNA melting temperature in the presence of charged amino acids and short peptides. Acidic residues (Glu, Asp) weakened the hydrogen bonds between strands, while basic ones (Arg, Lys) strengthened them. KEDP carries both kinds, and it shifted the melting temperature and stability of double-stranded DNA too [5].

That’s a plausible chemical basis for the chromatin data. It’s a long way from proof, since melting free DNA in a cuvette is a much simpler system than chromatin inside a nucleus.

How a tetrapeptide even gets into a cell is a separate question. A 2023 docking study modeled 26 ultrashort peptides against the amino acid transporters LAT1 and LAT2 and the peptide transporter PEPT1. KEDP landed among the most effective predicted ligands for all three transporters [6]. That’s computer modeling only. Nobody has measured KEDP uptake through those transporters in a published wet-lab study that we could find.

The tissue-specificity claim

The tissue-specific claim rests on explant work. A 2006 study cultured organotypic explants of heart, lung, prostate and pancreas from 3-week-old and 18-month-old rats, and exposed them to four bioregulators, Prostamax among them. At 0.05 ng/mL, each peptide showed a stimulating effect in its matching tissue culture compared with control explants [7].

It’s an interesting design, with tissue matched to peptide and age built in. We’d want to see it repeated with blinded scoring and the full dataset in English, though. The abstract is short and the paper is in Russian.

Reading this literature honestly

Question What’s published Study type
Chromatin decondensation in aged donor cells Yes, two cytogenetic studies [2, 3] In vitro, human leukocytes
Physical change in chromatin structure Endotherm shifts of 2.9 and 1.0 degrees C [4] Microcalorimetry
Direct DNA interaction Melting temperature shift [5] Cell-free
Cell entry route Predicted LAT1, LAT2, PEPT1 binding [6] In silico only
Tissue-matched activity Explant growth at 0.05 ng/mL [7] Rat organ culture

Two patterns stand out. Most of this work comes from a small circle of collaborating labs, and several key papers are only available in Russian with brief English abstracts. Neither of those makes the data wrong. They do mean the field hasn’t had much independent replication.

Where Prostamax research could go next

The cleanest next step is replication. Run the 2012 sister chromatid exchange and NOR counts in lymphocytes from a different donor pool, with a scrambled tetrapeptide (same four residues, shuffled sequence) as the control. If KEDP’s sequence matters, the scramble should fall flat. If it doesn’t, the effect is probably about charge, which would fit the 2015 melting data.

For how short chains like KEDP get classed and quality-checked, see our research peptides and chemicals primer.

References

  1. PubChem compound record: Prostamax, Lys-Glu-Asp-Pro (CID 9848296).
  2. Khavinson VKh, Lezhava TA, Malinin VV. Bull Exp Biol Med. 2004;137(1):78-81. PubMed 15085253
  3. Dzhokhadze TA, et al. Georgian Med News. 2012;(212):76-82. PubMed 23221144
  4. Meskhi T, et al. Biofizika. 2004;49(6):1091-1093. PubMed 15612551
  5. Solovyev AY, et al. Int J Biol Macromol. 2015;78:39-45. PubMed 25841380
  6. Khavinson VK, et al. Biomolecules. 2023;13(3):552. PubMed 36979488
  7. Zakutskii AN, et al. Adv Gerontol. 2006;19:93-96. PubMed 17152728

Disclaimer: This content is intended for research purposes only and is not meant to constitute medical advice.

Research-use notice

This educational material discusses laboratory research concepts only. Loti Labs products are intended strictly for research and development use and are not for human consumption.

Ready to explore?

Browse high-purity research materials by format or view the full catalog.